International Conference on Harmonisation: Proposed Change to Rodent Carcinogenicity Testing of Pharmaceuticals
Document ID: FDA-2013-N-0222-0001
Comments
Total: 11
-
Society of Toxicologic Pathology - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0002 Agency : FDA -
May 17,2013 11:59 PM ET
-
Dr Stephen Newsholme - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0003 Agency : FDA -
May 17,2013 11:59 PM ET
-
Novartis Pharmaceuticals Corp. - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0004 Agency : FDA -
May 17,2013 11:59 PM ET
-
Sanofi - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0005 Agency : FDA -
May 17,2013 11:59 PM ET
-
American Chemistry Council (ACC) - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0006 Agency : FDA -
May 17,2013 11:59 PM ET
-
Bristol-Myers Squibb - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0007 Agency : FDA -
May 17,2013 11:59 PM ET
-
Maria Beatriz da Silva Lima - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0008 Agency : FDA -
May 17,2013 11:59 PM ET
-
AbbVie - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0009 Agency : FDA -
May 17,2013 11:59 PM ET
-
BioReliance - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0010 Agency : FDA -
May 17,2013 11:59 PM ET
-
Pfizer Inc - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0011 Agency : FDA -
May 17,2013 11:59 PM ET
-
ICAPPP - Comment
Posted : 05/21/2013 ID ：FDA-2013-N-0222-0012 Agency : FDA -
May 17,2013 11:59 PM ET